SK Biopharmaceuticals Stock

Invest in stocks with eToro from 50 EUR

Detail	Data
Volume (24h):	100,165 shares
P/E Ratio:	/
Forward P/E:	/
EPS:	/
Forward EPS:	/
Number of Shares:	78,313,200 shares
Market Capitalization:	7,995,777,875,968.00 KRW

The interactive chart displays the price movement of SK Biopharmaceuticals shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

Dividend	Value
Dividend Amount	According to our data, the company SK Biopharmaceuticals does not currently pay dividends.
Annual Yield %:	-
Ex-dividend Date:	-
5-Year Avg Yield %:	-
Payout Ratio:	-
Last Dividend Value:	-
Last Dividend Date:	-

Analyst Forecast

Most analysts have issued a buy recommendation for SK Biopharmaceuticals stock. The current number of analysts covering this company is 17. The highest target price is 170000 KRW, while the lowest target price is 70000 KRW. The median target valuation set by analysts is 150000 KRW. These forecasts and recommendations provide insight into how analysts view the future stock performance of SK Biopharmaceuticals.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for SK Biopharmaceuticals stock is: buy
Number of Analysts:	17
Highest Target Price:	170000 KRW
Lowest Target Price:	70000 KRW
Median Target Price:	150000 KRW

Fundamental Indicators

Indicator	Data
Total Revenue:	547,596,271,616.00 KRW
Net Income:	240,738,041,856.00 KRW
Price-to-Book (P/B):	/
PEG Ratio:	/
Exchange:	KSE
Industry:	Biotechnology
Sector:	Healthcare
Number of Employees:	241
Country:	South Korea

Where to Buy SK Biopharmaceuticals Stock?

You can purchase SK Biopharmaceuticals stock on the KSE under the ticker symbol: 326030.KS. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on SK Biopharmaceuticals Stock

Indicator	Value
Company Revenue:	547,596,271,616.00 KRW
EBITDA:	113,767,227,392.00 KRW - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	-
Book Value Per Share:	-
Total Cash:	324,488,658,944.00 KRW
Total Cash per Share:	4,143.47 KRW
Total Debt:	184,482,152,448.00 KRW
Debt to Equity Ratio:	0.32
Quick Ratio	1.26
Current Ratio	1.64
Free Cash Flow	33,475,555,328.00 KRW
Operating Cash Flow	94,899,994,624.00 KRW
Gross Margins	92.13 %
EBITDA Margins	20.78 %
Operating Margins	24.94 %
Profit Margins	43.96 %
Return on Assets	6.8 %
Return on Equity	50.7 %
Earnings Growth (1 year)	2,712.4%
Revenue Growth (1 year)	28.6 %
Quarterly Earnings Year-over-Year Growth	2,712.4 %
Market Capitalization	7,995,777,875,968.00 KRW
Enterprise Value	7,883,487,444,992.00 KRW
EV/Revenue	14.397
EV/EBITDA	69.295
Float Shares	28,055,722 shares
Shares Outstanding	78,313,200 shares
Held Percent Insiders	0.64 %
Held Percent Institutions	11.94 %
Shares Short	-
Shares Short Prior Month	-
Date Short Interest	-
Short Percentage of Total Shares	-
Short Ratio	-
Beta	0.93
Short Percentage of Float	-
Implied Shares Outstanding	81,350,600

Frequently Asked Questions (FAQ)

1️⃣ Does SK Biopharmaceuticals pay dividends?

According to our data, the company SK Biopharmaceuticals does not pay dividends yet, even in 2025.

2️⃣ Where to buy SK Biopharmaceuticals shares?

SK Biopharmaceuticals shares are traded on the KSE stock exchange under the ticker: 326030.KS. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for SK Biopharmaceuticals shares?

According to our data, the recommendation for SK Biopharmaceuticals shares is from a total of 17 analysts. The average target price prediction is 150000 KRW per share.

4️⃣ What is the total number of shares and the value of SK Biopharmaceuticals on the stock exchange?

The total number of SK Biopharmaceuticals shares on the exchange is 78,313,200.00 shares, which at the current market capitalization gives the company a total valuation of 7,995,777,875,968.00 KRW.